Box G - Search Results

1

Immunotherapy with antibodies to the EGF receptor.

Dean C, Modjtahedi H, Eccles S, Box G, Styles J. Dean C, et al. Among authors: box g. Int J Cancer Suppl. 1994;8:103-7. doi: 10.1002/ijc.2910570722. Int J Cancer Suppl. 1994. PMID: 8194887

2

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.

Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S. Modjtahedi H, et al. Among authors: box g. Int J Cancer. 2003 Jun 10;105(2):273-80. doi: 10.1002/ijc.11055. Int J Cancer. 2003. PMID: 12673691

3

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: box gm. Cancer Res. 2000 Feb 15;60(4):1121-8. Cancer Res. 2000. PMID: 10706134

4

Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer.

Dean CJ, Eccles SA, Valeri M, Box G, Allan S, McFarlane C, Sandle J, Styles J. Dean CJ, et al. Among authors: box g. Cell Biophys. 1993 Jan-Jun;22(1-3):111-27. doi: 10.1007/BF03033870. Cell Biophys. 1993. PMID: 7534210

5

Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor.

Modjtahedi H, Eccles SA, Box G, Styles J, Dean CJ. Modjtahedi H, et al. Among authors: box g. Cell Biophys. 1993 Jan-Jun;22(1-3):129-46. doi: 10.1007/BF03033871. Cell Biophys. 1993. PMID: 7534211

6

Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.

Eccles SA, Modjtahedi H, Box G, Court W, Sandle J, Dean CJ. Eccles SA, et al. Among authors: box g. Invasion Metastasis. 1994-1995;14(1-6):337-48. Invasion Metastasis. 1994. PMID: 7657527 Review.

7

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.

Modjtahedi H, Eccles S, Box G, Styles J, Dean C. Modjtahedi H, et al. Among authors: box g. Br J Cancer. 1993 Feb;67(2):254-61. doi: 10.1038/bjc.1993.49. Br J Cancer. 1993. PMID: 7679281 Free PMC article.

8

Monoclonal antibodies for the treatment of metastases. Evaluation of strategies using a syngeneic rat model.

Eccles SA, Box G, Court W, Collins MK, Dean CJ. Eccles SA, et al. Among authors: box g. Cell Biophys. 1993 Jan-Jun;22(1-3):165-87. doi: 10.1007/BF03033873. Cell Biophys. 1993. PMID: 7889538

9

Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.

Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C. Modjtahedi H, et al. Among authors: box g. Cancer Res. 1994 Apr 1;54(7):1695-701. Cancer Res. 1994. PMID: 8137284

10

Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.

O-Charoenrat P, Rhys-Evans P, Modjtahedi H, Court W, Box G, Eccles S. O-Charoenrat P, et al. Among authors: box g. Int J Cancer. 2000 May 1;86(3):307-17. doi: 10.1002/(sici)1097-0215(20000501)86:3<307::aid-ijc2>3.0.co;2-i. Int J Cancer. 2000. PMID: 10760816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters